proprietary preparation obtained by extraction of Chlorella pyrenoidosa cells that selectively boost antibody response to the influenza vaccine; the bulk of the immunostimulatory activity resides in polysaccharide/protein complexes with molecular masses larger than 100 kDa that are composed primarily of galactose, rhamnose and arabinose; in human clinical trial 1/2007
